Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Company to Showcase Innovative Mammography Artificial Intelligence Solution at RSNA 2017 CHICAGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- RSNA 2017 -- iCAD, Inc. (NASDAQ:ICAD), a global leader in medical...
-
NASHUA, N.H. and MIAMI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced...
-
Total revenues increased 17% year-over-year; up 29% excluding MRI asset sale Conference Call today at 4:30 p.m. ET NASHUA, N.H., Nov. 08, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), an...
-
Technology utilizes advanced artificial intelligence to improve speed and accuracy in the detection of breast cancer KANSAS CITY, Mo., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Imaging for Women, a...
-
NASHUA, N.H., Nov. 01, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early...
-
The 12th annual awards recognized company’s state-of-the-art Artificial Intelligence solution for early breast cancer detection NASHUA, N.H., Oct. 26, 2017 (GLOBE NEWSWIRE) -- iCAD,...
-
Company will also host in-booth expert presentations and active peer-to-peer learning opportunities to review optimal strategies to improve outcomes in patient care using the Xoft System NASHUA, N.H....
-
NASHUA, N.H., Sept. 20, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early...
-
NASHUA, N.H., Sept. 03, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (Nasdaq:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early...
-
新罕布什尔州纳舒厄, Sept. 04, 2017 (GLOBE NEWSWIRE) -- 行业领先的高级图像分析和流程解决方案以及癌症早期识别和治疗放射疗法提供商iCAD, Inc. （Nasdaq:ICAD）今日宣布，公司的Xoft Axxent 的球囊施源器已获得中国食药监总局的批准，用于治疗早期乳腺癌。Xoft Axxent球囊施源器是Xoft®...